Breaking News, Collaborations & Alliances

Sanofi, Transgene in Long-Term Production Pact

Will serve as CMO for immunotherapy treatments

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi and Transgene SA have entered a collaboration for the creation of a new industrial platform for the production of immunotherapy products at Genzyme’s Polyclonals site in Lyon. Both companies will invest a combined $13 million. The platform will remain Sanofi’s exclusive property. The manufacturing suite is expected to be completed in 1Q15 with the first batches of commercial grade products expected in 2015.   Sanofi and Genzyme will serve as Transgene’s CMO for clinical and commercial bat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters